Dr. Şilem Özdem Alataş | Biological Sciences – Dokuz Eylül University, Turkey
Dr. Şilem Özdem Alataş is a rising academician and researcher in the field of pediatric infectious diseases, currently affiliated with Dokuz Eylül University Faculty of Medicine. With a focused dedication to neonatal sepsis, febrile neutropenia, and COVID-19-related complications in children, she has built a strong portfolio of research contributions that have gained both national and international attention. Her work reflects a passion for improving clinical outcomes in vulnerable pediatric populations through evidence-based practice and collaborative research.
Profile Verified:
🔹 Education:
Dr. Alataş completed her medical training and specialization in pediatric infectious diseases in Turkey, developing a strong foundation in both clinical care and research methodology. Her academic pathway at Dokuz Eylül University provided the technical and theoretical tools to address pressing challenges in pediatric infection management, diagnostics, and patient monitoring.
🔹 Experience:
With years of clinical and research experience in pediatric infections, Dr. Alataş has worked across multidisciplinary teams to address complex issues such as hematologic malignancy-related infections, neonatal diagnostic markers, and pediatric COVID-19 protocols. She is a contributing member of several institutional and multi-center studies and has co-authored peer-reviewed publications that are shaping pediatric healthcare policies and practices.
🔹 Research Interest:
Dr. Alataş’s research interests are centered around pediatric infectious diseases, particularly in high-risk groups such as neonates and immunocompromised children. She is focused on developing better diagnostic tools and treatment algorithms for febrile neutropenia, neonatal sepsis, systemic viral infections, and rare pediatric infectious diseases. Her investigations into the neutrophil-lymphocyte ratio, salivary biomarkers, and disease trends during pandemics highlight her dedication to data-driven clinical improvements.
🔹 Award:
Though she has not yet received a formal individual research award, Dr. Alataş’s scholarly contributions make her a strong candidate for the Best Researcher Award. Her articles have been cited across pediatric and infectious disease journals, and her research continues to inform clinical protocols and academic discussions in her field. Her recognition is growing steadily, and this nomination acknowledges her influence and potential for future innovation.
🔹 Publications:
-
📄 “Diagnostic value of neutrophil to lymphocyte ratio and mean platelet volume on early onset neonatal sepsis on term neonate” – Journal of Pediatric Intensive Care, 2021 – Cited by 34
-
🦠 “Etiology and factors affecting severe complications and mortality of febrile neutropenia in children with acute leukemia” – Turkish Journal of Hematology, 2023 – Cited by 11
-
🧪 “Evaluation of possible effects of the COVID-19 Pandemic on febrile neutropenia episodes in children with acute leukemia” – Journal of Pediatric Hematology/Oncology, 2022 – Cited by 3
-
🧬 “The clinical follow-up and management of COVID-19 in children and adolescents with an immunocompromised state or a malignancy” – Turkish Journal of Medical Sciences, 2022 – Cited by 3
-
👃 “Complications of acute bacterial rhinosinusitis in children: a single tertiary care center” – Journal of Pediatric Infection, 2022 – Cited by 3
-
🦷 “Association among COVID-19, multisystem inflammatory syndrome in children, and oral health status” – Brazilian Oral Research, 2023 – Cited by 1
-
🧫 “Newborn with branchial cleft cyst infection due to nocardia otitidiscaviarum” – The Pediatric Infectious Disease Journal, 2024 – Cited by 1
🔹 Conclusion:
Dr. Şilem Özdem Alataş stands out as a promising early-career researcher whose contributions to pediatric infectious disease research are both timely and impactful. Her work spans critical areas such as infection diagnostics, clinical management of immunocompromised children, and response to emerging health crises like COVID-19. With a solid publication record, growing citation count, and collaborative research network, she is well-positioned for continued academic and clinical impact. Her nomination for the Best Researcher Award reflects a recognition of both her past achievements and her future potential in global pediatric health research.